Comorbidities of epilepsy: current concepts and future perspectives

Area of Science:

• Neurology
• Internal Medicine
• Psychiatry

Background:

• Comorbidity is prevalent in epilepsy, with conditions such as depression, anxiety, and dementia occurring at significantly higher rates.
• These comorbidities can be up to eight times more common in individuals with epilepsy compared to the general population.

Purpose of the Study:

• To highlight the significant burden of comorbidity in epilepsy.
• To emphasize the need for improved screening tools and guidelines for early detection and management of comorbid conditions.
• To explore the impact of comorbidities on epilepsy outcomes and quality of life.

Main Methods:

• Review of existing literature on epilepsy and its associated comorbidities.
• Analysis of mechanisms linking epilepsy and comorbidities, including shared risk factors and bidirectional relationships.
• Examination of preliminary evidence on the effects of specific comorbidities on seizure outcomes.

Main Results:

• Epilepsy is frequently associated with a high burden of comorbidities, including neurological, psychiatric, and systemic diseases.
• Shared risk factors and bidirectional relationships are key mechanisms underlying these associations.
• Conditions like depression and migraine appear to negatively impact seizure control and quality of life in epilepsy patients.

Conclusions:

• There is an urgent need for validated screening instruments and clinical guidelines to address the high comorbidity burden in epilepsy.
• Further research is necessary to understand the interplay between epilepsy and comorbidities and to evaluate targeted interventions.
• Investigating comorbidities can enhance the understanding of epilepsy and aid in genetic study stratification.